Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Bosn J Basic Med Sci ; 22(2): 217-228, 2022 Apr 01.
Article in English | MEDLINE | ID: mdl-34813418

ABSTRACT

Emerging evidence has shown that protocatechuic acid (PCA) has antioxidant and anti-inflammatory effects. It can alleviate the injury of sciatic nerve, while the mechanism of its therapeutic effect on neuralgia remains unknown . In vivo, chromium bowel ligation was used to establish a chronic constriction injury (CCI) rat model to induce sciatic nerve pain, then two doses of PCA were used to treat CCI rats. In vitro, 10 ng/mL TNF-α was used to stimulate glial satellite cells derived from the dorsal root ganglia (DRG) L4-L6 of the sciatic nerve to simulate sciatic nerve pain. PCA relieved mechanical allodynia and thermal hyperalgesia in CCI rats. CCK-8 assay revealed that PCA inhibited the proliferation of glial satellite cells induced by TNF-α. Moreover, ELISA demonstrated that PCA could improve the inflammatory response of rats caused by CCI and cells induced by TNF-α. Next, RT-qPCR and Western blot assays testified that PCA blocked the c-Jun N-terminal kinase/the chemokine ligand 1/CXC chemokine receptor 2 (JNK/CXCL1/CXCR2) pathway by inhibiting CXCL1 levels in cells induced by TNF-α and DRG of CCI rats. In conclusion, PCA can alleviate neuropathic pain of CCI rats, improve oxidative stress by inhibiting the JNK/CXCL1/CXCR2 signaling pathway, which provides a new perspective for the treatment of neuropathic pain caused by CCI.


Subject(s)
Chemokine CXCL1 , Hydroxybenzoates , MAP Kinase Signaling System , Neuralgia , Receptors, Interleukin-8B , Animals , Chemokine CXCL1/antagonists & inhibitors , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Neuralgia/drug therapy , Rats , Receptors, Interleukin-8B/antagonists & inhibitors
2.
Zhongguo Zhen Jiu ; 25(3): 169-70, 2005 Mar.
Article in Chinese | MEDLINE | ID: mdl-16312922

ABSTRACT

OBJECTIVE: To search for an effective method for treatment of obstinate hiccup. METHODS: Ninety cases of obstinate hiccup secondary to cerebral diseases were randomly divided into 3 groups, 30 cases in each group. Group A were treated by injection of compound chlorpromazine into Yintang (Ex-HN 3), group B by intramuscular injection of compound chlorpromazine and group C by acupuncture at Yintang (Ex-HN 3). Their therapeutic effects were compared. RESULTS: The effective rate was 93.3% in the group A, 10.0% in the group B and 30.0% in the group C, the group A being better than the group B and the group C (P < 0.01). CONCLUSION: Injection of compound chlorpromazine into Yintang (Ex-HN 3) has a significant therapeutic effect on obstinate hiccup.


Subject(s)
Acupuncture Points , Hiccup , Acupuncture Therapy , Brain Diseases , Humans , Injections
SELECTION OF CITATIONS
SEARCH DETAIL
...